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Introduction
• Coronary Artery Disease (CAD) and Non-alcoholic fatty liver 
disease (NAFLD) are increasing in prevalence!1
• Both CAD and NAFLD have known associations with diabetes 
mellitus type 2, dyslipidemia, hypertension, and abdominal 
obesity.2
• Finding methods of early detection of CAD/NAFLD are 
important!
1. Pandyarajan V, Gish RG, Alkhouri N, et al. Screening for Nonalcoholic Fatty Liver Disease in the Primary 
Care Clinic. Gastroenterol Hepatol (N Y). 2019;15(7):357-365.
2. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. 
Atherosclerosis. 2007;191(2):235-240.
Introduction
• CT Coronary Artery Calcium Scans are used to 
monitor pre-symptomatic CAD!1
1. Cainzos-Achirica M, Di Carlo PA, Handy CE, et al. Coronary Artery Calcium Score: the 




– Can we determine whether there is an increased 
risk of NAFLD in a population with asymptomatic 
CAD?
• Hypothesis
– If patients have asymptomatic CAD, then they will 
have increased risk of NAFLD based on their 
common risk factor profile
Approach & Results
• Retrospective cross-sectional analysis of 134 
patient charts from 4/2017 to 1/2020
– The patients came from a community healthcare 
setting (low pre-test probability)
• Patients needed a positive CT CAC score and liver 
imaging within 3 years of the CAC study.
• Exclusion Criteria:
– Alcohol consumption: W> 7/wk, M> 14/wk
– Drugs: Glucocorticoids, Chemotherapy, Amiodarone, 
NRTI
– Chronic Viral Hepatitis: Types B, C, and D. 
Approach & Results
• Variables Obtained:
– Sex, TG, Total Cholesterol, HDL, LDL, BMI, HbA1c, 
BP, AST, ALT, ALP, Total Bilirubin
– FIB-4 and BARD Scores
• Statistics
– Chi-squared Analysis for each variable to CAD 
Severity and Hepatic Steatosis.
– Multivariate analysis for variables that had p < 
0.05, Hepatic Steatosis, and CAD severity
Approach & Results
• Results
– 15.7% of patients who underwent CT CAC had findings of hepatic 
steatosis on abdominal imaging
– CAD severity was not associated with presence of hepatic steatosis (p 





• There was no association between CAD severity and 
presence of hepatic steatosis. 
• Obesity and diabetes were significant contributors to 
the presence of CAD and hepatic steatosis
– This supports the postulate that insulin resistance 
promotes fatty acid accumulation and accelerates 
atherosclerosis1. 
• Diet, exercise, and weight loss should be emphasized 
lifestyle modifications2.
• Limitations: No liver biopsy or Fibroscan data to 
confirm liver fibrosis. Study population had in general 
less diabetes, high TG, and obesity than general 
population3. 
1. Jaruvongvanich V, Wirunsawanya K, Sanguankeo A, Upala S. Nonalcoholic fatty liver disease is associated with 
coronary artery calcification: A systematic review and meta-analysis. Dig Liver Dis. 2016;48(12):1410-1417.
2. Chalasani N, Younossi Z, Lavine JE, et al. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: 
Practice Guideline From the American Association for the Study of Liver Diseases. Hepatology. 2019;67(1):328-357
3. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic 
assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84
Future Directions
• Exploring the effects of weight loss and 
diabetes control on NAFLD and CAD together 
prospectively. 
Acknowledgements
• TJUH Division of Gastroenterology and 
Hepatology
